You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Harvard Business School
McKesson
Johnson and Johnson
Baxter

Last Updated: June 4, 2020

DrugPatentWatch Database Preview

ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Acetaminophen, Aspirin, And Codeine Phosphate, and when can generic versions of Acetaminophen, Aspirin, And Codeine Phosphate launch?

Acetaminophen, Aspirin, And Codeine Phosphate is a drug marketed by Mikart and is included in three NDAs.

The generic ingredient in ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE is acetaminophen; aspirin; codeine phosphate. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; aspirin; codeine phosphate profile page.

Summary for ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE
Drug patent expirations by year for ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE

US Patents and Regulatory Information for ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mikart ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE acetaminophen; aspirin; codeine phosphate CAPSULE;ORAL 081095-001 Oct 26, 1990 DISCN No No   Start Trial   Start Trial   Start Trial
Mikart ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE acetaminophen; aspirin; codeine phosphate CAPSULE;ORAL 081096-001 Oct 26, 1990 DISCN No No   Start Trial   Start Trial   Start Trial
Mikart ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE acetaminophen; aspirin; codeine phosphate CAPSULE;ORAL 081097-001 Oct 26, 1990 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Harvard Business School
McKesson
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.